Heme Part 1 Flashcards
Hemostasis
Arrest of bleeding
Hemarthrosis
Bleeding into joint
Virchows Triangle
- Vascular component
- Platelets
- Plasma Proteins
Purpura
Superficial dermatological bleeding due to functional platelet problem or vascular abnormality
>.5 cm
Petechiae
Usually from thrombocytopenia. Not a functional problem. <.5cm
Romiplostim
Med used during chemotherapy and for ITP when platelet counts are low. Attaches to thrombopoietin receptor and activates STAT5 for megakaryocyte proliferation and differentiation and JAK2 for protein production and shedding of platelets.
Thrombopoietin
Stimulus for megakaryocytes when there is a low platelet count causing megakaryocyte nuclei to divide
EDTA
Calcium chelator that makes it easier for antibodies to attach to platelets
Aggregation Dependent GPIIbIIIa
Epi, ADP, collagen
Adhesion dependent
Ristocetin
Dependent on presence of GPI and vWF
ASA
Irreversible COX inhibitor that blocks production of thromboxane (7 - 10 days)
NSAIDS
Reversible COX inhibitor that blocks production of thromboxane
Clopidogrel
Plavix. ADP receptor inhibitor block activation of platelets (GPIIbIIIa).
Prasugrel (Effient)
ADP receptor inhibitor that blocks activation of platelets (GPIIbIIIa)
Ticlopidine (Ticlid)
ADP receptor inhibitor that blocks activation of platelets (GPIIBIIIA)
Abciximab (ReoPro)
GPIIBIIIA inhibitor blocking platelet aggregation. Can still have adhesion.
Eptifibatid (Integrilin)
GPIIBIIIA inhibitor blocking platelet aggregation. Can still have adhesion.
Tirofiban (Aggrastat)
GPIIBIIIA inhibitor blocking platelet aggregation. Can still have adhesion.
Dipyridamole (Persantine)
Adenosine reuptake inhibitor increasing cAMP which potentiates PGI2causing vasodilation and thus decrease platelet aggregation
May-Hegglin Anomaly
Autosomal dominant thrombocytopenia - non-muscle myosin heavy chain 11a causing mild to mod bruising and large platelets
Wiskott-Aldrich Syndrome
X-linked thrombocytopenia. Defect in WASP protein - cannot make IgM antibodies leading to eczema, bloody diarrhea, and immunodeficiency
Congenital Amegakaryocytic Thrombocytopenia
Autosomal recessive thrombocytopenia caused by a platelet growth factor receptor mutation. No megakaryocytes so will need a bone marrow transplant.
Thiazides
First line HTN drug that can have a side effect of thrombocytopenia
Tolbutamide
DM type 2 medication to increase insulin production. May have a side effect of thrombocytopenia.
Evans Syndrome
An autoimmune hemolytic anemia with reticulocytosis and spherocytes that can occur with ITP
WinRho
Ab to Rh factor in Rh + patients
Dexamethazone
Suppress production. More effective with Rituximab for ITP.
Rituximab
Attaches to CD20 on B cells and will not be able to make plasma cell antibodies
Danazol
Attenuated androgen
Romiplostim and eltrombopag
Thrombopoietin receptor agonist
TTP Pentad
Fever Thrombocytopenia Microangiopathic hemolytic anemia Transient neurological deficits Renal failure